Legal & General Group
IBIO icon

Legal & General Group’s iBio IBIO Stock Holding History

Legal & General Group’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-35
Closed -$8K – 3586
2022
Q1 		$8K Hold
35
– – ﹤0.01% 3448
2021
Q4 		$10K Hold
35
– – ﹤0.01% 3462
2021
Q3 		$19K Hold
35
– – ﹤0.01% 3294
2021
Q2 		$27K Sell
35
-10
-22% -$7.29K ﹤0.01% 3176
2021
Q1 		$35K Buy
45
+4
+10% +$3.48K ﹤0.01% 2942
2020
Q4 		$21K Buy
41
+27
+193% +$22K ﹤0.01% 3068
2020
Q3 		$14K Sell
14
-1
-7% -$1.45K ﹤0.01% 3098
2020
Q2 		$17K Buy
+15
New +$9.81K ﹤0.01% 3128

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Legal & General Group's IBIO Position: Q2 2022 in Review

Legal & General Group sold out of iBio (IBIO) in Q2 2022, closing a stake of 35 shares — an estimated $8K sold.

Legal & General Group first reported a position in IBIO in Q2 2020 and held it in 8 quarters. The position peaked at $35K in Q1 2021. 53 funds tracked by Wall St. Rank hold IBIO as of Q2 2022.

  • Legal & General Group reported no remaining iBio position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 35 iBio shares in Q2 2022, an estimated $8K.
  • Legal & General Group first reported a position in iBio in Q2 2020 and held it in 8 quarters.
  • Legal & General Group's iBio position peaked at $35K in Q1 2021.
  • 53 funds tracked by Wall St. Rank held iBio as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.